GLOW combines three complementary peptides, BPC-157, TB-500 and GHK-Cu. Each has its own published preclinical literature covering collagen production, tissue regeneration and skin repair. No study covers the three together, so the research below belongs to the individual components.
PEPTIDE BLEND · RESEARCH MONOGRAPH · BPC-157 + TB-500 + GHK-CU
Mechanisms described in the published preclinical literature.
Reported to promote blood vessel formation, enhance tissue granulation and modulate nitric oxide signalling, supplying vascular support to damaged tissue.
Reported to increase cell migration and support cytoskeletal remodelling through the thymosin beta-4 pathway, with reduced fibrotic scarring described.
Reported to stimulate type I and III collagen synthesis and to deliver copper to repair sites, with broad gene-expression effects described.
Findings from the published literature, as the studies reported them. Where a finding comes from a human trial, it says so. None is a claim about the material supplied here.
GHK-Cu associated with collagen synthesis, while BPC-157 and TB-500 are described in epithelial repair and reduced scarring.
Pickart & Margolina 2018
TB-500 in actin remodelling, BPC-157 in tendon fibroblast viability, GHK-Cu in vascularisation.
Chi et al. 2017
All three components show anti-inflammatory properties through different mechanisms in animal models.
Hsieh et al. 2016
Coordinated extracellular matrix deposition described for functional, less fibrotic tissue regeneration.
Brcic et al. 2011
A single vial containing three peptides: GHK-Cu at 50mg, BPC-157 at 10mg and TB-500 at 10mg, for a 70mg total fill. The certificate reports measured content for each one separately.
They are not studied together. Each has its own separate preclinical literature, and the components were selected because their individually studied pathways sit in adjacent areas: copper-dependent matrix remodelling, connective tissue repair and cytoskeletal cell migration. Any combined effect is unstudied.
No. It is not an approved drug and has not been evaluated by the FDA for any use. It is supplied strictly as a reference material for in-vitro laboratory research.
Store the sealed vial at −20°C. Once reconstituted, hold at 2–8°C and protect from light; we do not publish an in-use shelf life for reconstituted material because we have not measured one on this material. Protect from direct light at all times.
Third-party RP-HPLC for purity and LC-MS for identity, reported per component rather than as a blended figure, plus endotoxin testing.
There is none for the blend itself. The literature cited on this page covers the three components individually, in separate studies. Anyone treating those findings as evidence for the combination is over-reading them.
Each entry opens a PubMed search for that title rather than a fixed identifier, so the link resolves to the current record.
For laboratory research use only. Not a drug, supplement or medical product, and not for human or animal use. Every finding referenced on this page comes from published preclinical or laboratory research and is not a claim about this product.
